Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BYBiomedicines

Antibody Targeting Soluble NKG2D Ligand MIC Enhances Adoptive T-Cell Therapy in an NK Cell-Dependent Mechanism

  • Fahmin Basher1
  • Tyler A. Smith2
  • Mark P. Rubinstein3
  • Jennifer D. Wu3
  1. 1Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, School of Medicine, Durham, NC 27710, USA;
  2. 2Department of Urology, Feinberg School of Medicine, , Chicago, IL 60611, USA;
  3. 3Department of Microbiology and Immunology, , Charleston, SC 29425, USA;
Read full textPDFCite

Related

  1. A neutralizing monoclonal antibody targeting species B adenoviruses largely mimics the DSG2 receptor engagement mechanism
    Emilie Vassal-Stermann, Camille Berthollet, Wenli Zhang +6
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseCrossref
  2. Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models
    S. Subramanian, P. C. High, C. Guernsey-Biddle +7
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  3. 837 Targeting a CD36-dependent macrophage immunometabolic program enhances PARP inhibitor response in BRCA-associated TNBC
    Julie Collins, Anita Mehta, Adam Nelson +20
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. 716 TOMM20 overexpression enhances T-cell mitochondrial fitness and improves adoptive cell therapy in sarcoma
    Zhao Lin, Megan Roche, Diana Menezes +3
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  5. Targeting BIGH3 in selected solid tumors through a pH-Dependent antibody engineering strategy
    Karine Aguéra, Sahar Kassem, Sophie Bachy +6
    Biochemistry and Biophysics ReportsPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyDOAJEurope PMCEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{basher2026antibody,
  title = {{Antibody Targeting Soluble NKG2D Ligand MIC Enhances Adoptive T-Cell Therapy in an NK Cell-Dependent Mechanism}},
  author = {Fahmin Basher and Tyler A. Smith and Mark P. Rubinstein and Jennifer D. Wu},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13702291},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Antibody Targeting Soluble NKG2D Ligand MIC Enhances Adoptive T-Cell Therapy in an NK Cell-Dependent Mechanism
AU  - Fahmin Basher
AU  - Tyler A. Smith
AU  - Mark P. Rubinstein
AU  - Jennifer D. Wu
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13702291
SN  - 2227-9059
ER  -